(2R)-2-[6-(4-Chlorophenoxy)hexyl]-2-oxiranecarboxylic acid sodium

CAS : 828934-41-4

Ref. 3D-BE164435

Informations sur le produit

• Nom: (2R)-2-[6-(4-Chlorophenoxy)hexyl]-2-oxiranecarboxylic acid sodium
• Marque: Biosynth
• Description: (+)-Etomoxir sodium salt hydrate is a chemical compound classified as a carnitine palmitoyltransferase 1 (CPT1) inhibitor, which is a compound derived synthetically. Its mode of action involves the inhibition of the enzyme CPT1, which is pivotal in the transport of long-chain fatty acids into the mitochondria for β-oxidation. This inhibition effectively blocks fatty acid oxidation pathways, leading to alterations in metabolic states.Etomoxir is commonly utilized in scientific research to study metabolic processes, particularly those related to energy metabolism and metabolic disorders. It serves as a valuable tool in exploring mechanisms involved in diabetes, obesity, and cardiovascular diseases by allowing researchers to scrutinize the metabolic adaptations to impaired fatty acid oxidation. Furthermore, it is used in cellular and animal models to investigate metabolic inflexibility and mitochondrial function. Its application extends to cancer research, where metabolic reprogramming is a focus, aiding in the understanding of tumor progression and potential therapeutic interventions targeting metabolic pathways.

Propriétés chimiques

• Masse moléculaire: 320.74 g/mol
• Formule: C₁₅H₁₈ClNaO₄